Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose ...
Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...
Jefferies analysts highlighted stocks that looked cheap based on valuation, and that had recent upward revisions and higher beta scores.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback